Gene action in the aging brain: An evolutionary biological perspective

Neurobiology of Aging

Volumn 23, Issue 5, 2002, Pages 647-654

  Martin, George M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Biological perspective; Brain aging; Gene action

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA;

AGING; ALLELE; ARTICLE; BRAIN FUNCTION; BRAIN MATURATION; GENE ACTIVITY; GENE EXPRESSION; GENE SILENCING; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; LIFESPAN; MUTATION; NATURAL SELECTION; NEUROBIOLOGY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL;

AGED; AGING; BRAIN; EVOLUTION; GENE EXPRESSION; HUMANS;

EID: 0036753130     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00341-4     Document Type: Article

References (89)

1. Adams J.D., Chang M.L., Klaidman L. Parkinson's disease-redox mechanisms. Curr. Med. Chem. 8:2001;809-814.
2. Alvarez H.P. Grandmother hypothesis, and primate life histories. Am. J. Phys. Anthropol. 113:2000;435-450.
3. Austad SN. Why we age: what science is discovering about the body's journey through life. New York: Wiley, 1997.
4. Bartke A., Brown-Borg H., Mattison J., Kinney B., Hauck S., Wright C. Prolonged longevity of hypopituitary dwarf mice. Exp. Gerontol. 36:2001;21-28.
5. Bastin P., Coppens I., Saint-Remy J.M., Baudhuin P., Opperdoes F.R., Courtoy P.J. Identification of a specific epitope on the extracellular domain of the LDL-receptor of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 63:1994;193-202.
6. Bigler E.D., Lowry C.M., Anderson C.V., Johnson S.C., Terry J., Steed M. Dementia, quantitative neuroimaging, and apolipoprotein E genotype. AJNR Am. J. Neuroradiol. 21:2000;1857-1868.
7. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C.et al. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343:2000;450-456.
8. Borst P., Fairlamb A.H. Surface receptors, and transporters of Trypanosoma brucei. Annu. Rev. Microbiol. 52:1998;745-778.
9. Caselli R.J., Graff-Radford N.R., Reiman E.M., Weaver A., Osborne D., Lucas J.et al. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. Neurology. 53:1999;201-207.
10. Charlesworth B. Evolution in age-structured populations. 2nd ed. Cambridge, UK: Cambridge University Press, 1994.
11. Clancy D.J., Gems D., Harshman L.G., Oldham S., Stocker H., Hafen E.et al. Extension of life span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science. 292:2001;104-106.
12. Corder E.H., Basun H., Fratiglioni L., Guo Z., Lannfelt L., Viitanen M.et al. Inherited frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+. Ann. N. Y. Acad. Sci. 908:2000;295-298.
13. Curtsinger J.W., Pletcher S.D. Mortality plateaus, and the evolution of senescence: why are old-age mortality rates so low? Evolution. 52:1998;454-464.
14. DeMattos R.B., Curtiss L.K., Williams D.L. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J. Biol. Chem. 273:1998;4206-4212.
15. DeMattos R.B., Rudel L.L., Williams D.L. Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. J. Lipid Res. 42:2001;976-987.
16. Dik M.G., Jonker C., Bouter L.M., Geerlings M.I., van Kamp G.J., Deeg D.J. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology. 54:2000;1492-1497.
17. Duffy P.H., Leakey J.E., Pipkin J.L., Turturro A., Hart R.W. The physiologic, neurologic, and behavioral effects of caloric restriction related to aging, disease, and environmental factors. Environ. Res. 73:1997;242-248.
18. Finch C.E., Sapolsky R.M. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol. Aging. 20:1999;407-428.
19. Fischer RA. The genetical theory of natural selection. Oxford: Clarendon Press, 1930.
20. Friedman D.B., Johnson T.E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life, and reduces hermaphrodite fertility. Genetics. 118:1988;75-86.
21. Gershon H., Gershon D. Detection of inactive enzyme molecules in ageing organisms. Nature. 227:1970;1214-1217.
22. Gillett M.P., Owen J.S. Characteristics of the binding of human, and bovine high-density lipoproteins by bloodstream forms of the African trypanosome, Trypanosoma brucei brucei. Biochim. Biophys. Acta. 1123:1992;239-248.
23. Greenwood P.M., Sunderland T., Friz J.L., Parasuraman R. Genetics, and visual attention: selective deficits in healthy adult carriers of the epsilon4 allele of the apolipoprotein E gene. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11661-11666.
24. Guarente L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14:2000;1021-1026.
25. Haldane JBS. New paths in genetics. New York: Harper Brothers, 1942.
26. Hamilton W.D. The moulding of senescence by natural selection. J. Theor. Biol. 12:1966;12-45.
27. Hodes R.J., McCormick A.M., Pruzan M. Longevity assurance genes: how do they influence aging, and life span? J. Am. Geriatr. Soc. 44:1996;988-991.
28. Holliday R. Mutations, and epimutations in mammalian cells. Mutat. Res. 250:1991;351-363.
29. Horejsi B., Ceska R. Apolipoproteins, and atherosclerosis. Apolipoprotein E, and apolipoprotein (a) as candidate genes of premature development of atherosclerosis. Physiol. Res. 49(Suppl 1):2000;S63-S69.
30. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing, and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 403:2000;795-800.
31. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing, and neoplasia in human colon. Nat. Genet. 7:1994;536-540.
32. Issa J.P., Vertino P.M., Boehm C.D., Newsham I.F., Baylin S.B. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging, and carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11757-11762.
33. Jonker C., Schmand B., Lindeboom J., Havekes L.M., Launer L.J. Association between apolipoprotein E epsilon4, and the rate of cognitive decline in community-dwelling elderly individuals with, and without dementia. Arch. Neurol. 55:1998;1065-1069.
34. Jung C., Rong Y., Doctrow S., Baudry M., Malfroy B., Xu Z. Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress, and prolong survival in a mouse amyotrophic lateral sclerosis model. Neurosci. Lett. 304:2001;157-160.
35. Kaeberlein M., McVey M., Guarente L. The SIR2/3/4 complex, and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13:1999;2570-2580.
36. Kelly A., Mullany P.M., Lynch M.A. Protein synthesis in entorhinal cortex, and long-term potentiation in dentate gyrus. Hippocampus. 10:2000;431-437.
37. Kenyon C. A conserved regulatory system for aging. Cell. 105:2001;165-168.
38. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type [see comments]. Nature. 366:1993;461-464.
39. Kirk K.M., Blomberg S.P., Duffy D.L., Heath A.C., Owens I.P., Martin N.G. Natural selection, and quantitative genetics of life history traits in Western women: a twin study. Evolution Int. J. Org. Evolution. 55:2001;423-435.
40. Kirkwood T.B. The nature, and causes of ageing. Ciba. Found Symp. 134:1988;193-207.
41. Kirkwood T.B., Austad S.N. Why do we age? Nature. 408:2000;233-238.
42. Larsen P.L., Albert P.S., Riddle D.L. Genes that regulate both development, and longevity in Caenorhabditis elegans. Genetics. 139:1995;1567-1583.
43. Lederberg J. The meaning of epigenetics. The Scientist. 15:2001;6-7.
44. Lin Y.J., Seroude L., Benzer S. Extended life span, and stress resistance in the Drosophila mutant methuselah. Science. 282:1998;943-946.
45. Mann D.M.A., Sinclair K.G.A. The quantitative assessment of lipofuscin pigment, cytoplasmic RNA, and nucleolar volume in senile dementia. Neuropathol. Appl. Neurobiol. 4:1978;129-135.
46. Martin G.M. Genetics, and the pathobiology of ageing. Philos. Trans. R Soc. Lond. B Biol. Sci. 352:1997;1773-1780.
47. Martin G.M. APOE alleles, and lipophylic pathogens. Neurobiol. Aging. 20:1999;441-443.
48. Martin G.M., Austad S.N., Johnson T.E. Genetic analysis of ageing: role of oxidative damage, and environmental stresses. Nat. Genet. 13:1996;25-34.
49. Martin G.M., Ogburn C.E., Colgin L.M., Gown A.M., Edland S.D., Monnat R.J. Somatic mutations are frequent, and increase with age in human kidney epithelial cells. Hum. Mol. Genet. 5:1996;215-221.
50. Medawar DB. Old-age, and natural death; uniqueness of the individual. London: Methuen Co. Ltd., 1957. p. 17-70.
51. Medawar PB. An unsolved problem of biology. In: Medawar PB, editor. The uniqueness of the individual. London: Methuen Co. Ltd., 1957. p. 44-70.
52. Migeon B.R., Axelman J., Beggs A.H. Effect of ageing on reactivation of the human X-linked HPRT locus [see comments]. Nature. 335:1988;93-96.
53. Mueller L.D., Rose M.R. Evolutionary theory predicts late life mortality plateaus. Proc. Natl. Acad. Sci. U.S.A. 93:1996;15249-15253.
54. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K.et al. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;759-767.
55. Ogburn C.E., Austad S.N., Holmes D.J., Kiklevich J.V., Gollahon K., Rabinovitch P.S.et al. Cultured renal epithelial cells from birds and mice: enhanced resistance of avian cells to oxidative stress and DNA damage. J. Gerontol. A Biol. 53:1998;B287-B292.
56. Ogburn C.E., Carlberg K., Ottinger M.A., Holmes D.J., Martin G.M., Austad S.N. Exceptional cellular resistance to oxidative damage in long-lived birds requires active gene expression. J. Gerontol. A Biol. 56:2001;B468-B474.
57. Packer C., Tatar M., Collins A. Reproductive cessation in female mammals. Nature. 392:1998;807-811.
58. Parkes T.L., Elia A.J., Dickinson D., Hilliker A.J., Phillips J.P., Boulianne G.L. Extension of Drosophila life span by overexpression of human SOD1 in motorneurons. Nat. Genet. 19:1998;171-174.
59. Peccei J.S. A critique of the grandmother hypotheses: old, and new. Am. J. Hum. Biol. 13:2001;434-452.
60. Perls T.T., Fretts R.C. The evolution of menopause, and human life span. Ann. Hum. Biol. 28:2001;237-245.
61. Plassman B.L., Welsh-Bohmer K.A., Bigler E.D., Johnson S.C., Anderson C.V., Helms M.J.et al. Apolipoprotein E epsilon4 allele, and hippocampal volume in twins with normal cognition. Neurology. 48:1997;985-989.
62. Promislow D.E., Tatar M. Mutation, and senescence, where genetics, and demography meet. Genetica. 102/103:1998;299-314.
63. Promislow D.E., Tatar M., Khazaeli A.A., Curtsinger J.W. Age-specific patterns of genetic variance in Drosophila melanogaster. Part I. Mortality. Genetics. 143:1996;839-848.
64. Rattan S.I. Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31:1996;33-47.
65. Ravaja N., Raikkonen K., Lyytinen H., Lehtimaki T., Keltikangas-Jarvinen L. Apolipoprotein E phenotypes, and cardiovascular responses to experimentally induced mental stress in adolescent boys. J. Behav. Med. 20:1997;571-587.
66. Reiman E.M., Caselli R.J., Chen K., Alexander G.E., Bandy D., Frost J. Declining brain activity in cognitively normal apolipoprotein E varepsilon4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3334-3339.
67. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S.et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon4 allele for apolipoprotein E. N. Engl. J. Med. 334:1996;752-758.
68. Riley K.P., Snowdon D.A., Saunders A.M., Roses A.D., Mortimer J.A., Nanayakkara N. Cognitive function, and apolipoprotein E in very old adults: findings from the Nun Study. J. Gerontol. B Psychol. Sci. Soc. Sci. 55:2000;S69-S75.
69. Rogina B., Reenan R.A., Nilsen S.P., Helfand S.L. Extended life span conferred by cotransporter gene mutations in Drosophila. Science. 290:2000;2137-2140.
70. Rose M.R. Life history evolution with antagonistic pleitropy, and ovelapping generations. Theor. Popul. Biol. 28:1985;342-358.
71. Rose MR. Evolutionary biology of aging. Oxford: Oxford University Press, 1991.
72. Rothstein M. Biochemical approaches to aging. New York: Academic Press, 1982.
73. Saunders A.M. Apolipoprotein E, and Alzheimer disease: an update on genetic, and functional analyses. J. Neuropathol. Exp. Neurol. 59:2000;751-758.
74. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
75. Shanley D.P., Kirkwood T.B. Evolution of the human menopause. Bioessays. 23:2001;282-287.
76. Small B.J., Graves A.B., McEvoy C.L., Crawford F.C., Mullan M., Mortimer J.A. Is APOE-epsilon4 a risk factor for cognitive impairment in normal aging? Neurology. 54:2000;2082-2088.
77. Small G.W., Mazziotta J.C., Collins M.T., Baxter L.R., Phelps M.E., Mandelkern M.A.et al. Apolipoprotein E type 4 allele, and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA. 273:1995;942-947.
78. Swisshelm K., Disteche C.M., Thorvaldsen J., Nelson A., Salk D. Age-related increase in methylation of ribosomal genes, and inactivation of chromosome-specific rRNA gene clusters in mouse. Mutat. Res. 237:1990;131-146.
79. Tatar M., Kopelman A., Epstein D., Tu M.P., Yin C.M., Garofalo R.S. A mutant Drosophila insulin receptor homolog that extends life span, and impairs neuroendocrine function. Science. 292:2001;107-110.
80. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends life span in Caenorhabditis elegans. Nature. 410:2001;227-230.
81. Tissenbaum H.A., Ruvkun G. An insulin-like signaling pathway affects both longevity, and reproduction in Caenorhabditis elegans. Genetics. 148:1998;703-717.
82. Van Voorhies W.A., Ward S. Genetic, and environmental conditions that increase longevity in Caenorhabditis elegans decrease metabolic rate. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11399-11403.
83. Vandeweerd V., Black S.J. Selective inhibition of the uptake by bloodstream form Trypanosoma brucei brucei of serum lipoprotein-associated phospholipid, and cholesteryl ester. Mol. Biochem. Parasitol. 41:1990;197-206.
84. Vaupel J.W., Carey J.R., Christensen K., Johnson T.E., Yashin A.I., Holm N.V.et al. Biodemographic trajectories of longevity. Science. 280:1998;855-860.
85. Wareham K.A., Lyon M.F., Glenister P.H., Williams E.D. Age-related reactivation of an X-linked gene. Nature. 327:1987;725-727.
86. Williams G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 11:1957;398-411.
87. Wilson A.C. The molecular basis of evolution. Sci. Am. 253:1985;164-173.
88. Wood JW, Weeks SC, Bentley GR, Weiss KM. Human population biology, and the evolution of aging. In: Crews DE, Garruto RM, editors. Biological anthropology, and aging. Perspectives on human variation over the life span. Oxford: Oxford University Press, 1994. p. 19-75.
89. Xu P.T., Schmechel D., Rothrock-Christian T., Burkhart D.S., Qiu H.L., Popko B.et al. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial, and neuronal immunoreactivity in central nervous system not observed in wild type mice. Neurobiol. Dis. 3:1996;229-245.